Compound ID | 3201
Synonym(s): Prothionamide
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Mycolic acid synthesis inhibitor. Enoyl-acyl ACP reductase InhA inhibitor |
| Target Pathogen: | Active against tuberculous and non-tuberculous mycobacterial infections |
| Description: | Synthetic compound; pyridine derivative of ethionamide; may be included in treatment of MDR or rifampicin resistant TB (second-line anti-TB drug) |
| Year first mentioned: | 1950 |
| Highest development stage: | Phase 3 (NCT06081361) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/666418 |
| Guide to Pharmacology: | protionamide |
| Citation: | https://www.sciencedirect.com/science/article/pii/0041387968900482?via%3Dihub |